5:20 PM
 | 
Mar 22, 2013
 |  BC Extra  |  Company News

FDA approves TOBI Podhaler

FDA approved an NDA late Friday from Novartis AG (NYSE:NVS; SIX:NOVN) for TOBI Podhaler to...

Read the full 62 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >